Development of CT-0508, a First-in-Class CAR-M, For Solid Tumor Immunotherapy

Time: 12:00 pm
day: Clinical Development - Day 1 am

Details:

  • Key rationale for development of monocyte/ macrophage based therapeutics
  • Overview of Carisma’s proprietary engineered mono/macrophage cell therapy technology
  • CT-0508: clinical trial in progress update

Speakers: